Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Total Non-Current Liabilities: 2024

Historic Total Non-Current Liabilities for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Dec 2024 value amounting to $79.3 million.

  • Day One Biopharmaceuticals' Total Non-Current Liabilities was N/A to $62.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.2 million, marking a year-over-year change of. This contributed to the annual value of $79.3 million for FY2024, which is N/A change from last year.
  • As of FY2024, Day One Biopharmaceuticals' Total Non-Current Liabilities stood at $79.3 million.
  • Day One Biopharmaceuticals' 5-year Total Non-Current Liabilities high stood at $79.3 million for FY2024, and its period low was $79.3 million during FY2024.
  • For the 1-year period, Day One Biopharmaceuticals' Total Non-Current Liabilities averaged around $79.3 million, with its median value being $79.3 million (2024).